Global and national policies have refocused attention on postpartum family planning as an important component of ensuring healthy outcomes for women and babies. The progesterone vaginal ring (PVR) is used to extend the contraceptive effectiveness of lactational amenorrhea among breastfeeding women. Clinical trials have proven the PVR to be safe and effective; it is currently registered in eight Latin American countries. There is a need to assess acceptability prior to introduction into country programs, and the Population Council conducted PVR acceptability studies in Kenya, Nigeria, and Senegal. This report represents the results from a pooled analysis of data from the three countries. Information was collected from various stakeholders to evaluate factors influencing acceptability, including PVR users, health care providers, partners, and community members. The PVR was found to be an acceptable method of contraception in Kenya, Nigeria, and Senegal and we can extrapolate that it will be just as acceptable in other developing countries. There is widespread community support for the product, and it is feasible to integrate it into existing health systems.
RamaRao, Saumya, Heather Clark, Deepa Rajamani, Salisu Mohammed Ishaku, Babacar Mane, Francis Obare, Harriet Birungi, Nafissatou Diop, Wilson Liambila, Fatou Mbow, Chi-Chi Undie, Godwin Unumeri, and John Townsend. 2015. "Progesterone vaginal ring: Results of a three-country acceptability study." New York: Population Council.
The Progesterone Contraceptive Vaginal Ring: Expanding Contraceptive Options in Africa